Retraction notice to "MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway" [Biomed. Pharmacother. 107 (2018) 1744-1753].
作者信息
Wang Tao, Jiang Lihua, Wei Xiaoyong, Liu Bo, Zhao Junbo, Xie Peilin, Yang Bo, Wang Lijuan
机构信息
Department of Anesthesiology, The Third Affiliated Hospital of Zhengzhou University, No. 7, Zhengzhou Kangfufront Street, Zhengzhou City 450052, Henan Province, China.
Department of Anesthesiology, The Third Affiliated Hospital of Zhengzhou University, No. 7, Zhengzhou Kangfufront Street, Zhengzhou City 450052, Henan Province, China.
出版信息
Biomed Pharmacother. 2023 Apr;160:114275. doi: 10.1016/j.biopha.2023.114275. Epub 2023 Jan 31.
PMID:36725473
Abstract
摘要
相似文献
1
Retraction notice to "MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway" [Biomed. Pharmacother. 107 (2018) 1744-1753].撤回声明：“MiR-21-3p通过激活TRP信号通路加重急性出血坏死性胰腺炎大鼠的损伤”[《生物医学与药物治疗》107 (2018) 1744 - 1753]
Biomed Pharmacother. 2023 Apr;160:114275. doi: 10.1016/j.biopha.2023.114275. Epub 2023 Jan 31.
2
MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway.miR-21-3p 通过激活 TRP 信号通路加重急性出血坏死性胰腺炎大鼠的损伤。
Biomed Pharmacother. 2018 Nov;107:1744-1753. doi: 10.1016/j.biopha.2018.08.164. Epub 2018 Sep 10.
3
Retraction notice to: "Long noncoding RNA RMRP upregulation aggravates myocardial ischemia-reperfusion injury by sponging miR-206 to target ATG3 expression" [Biomed. Pharmacother. 109 (2018) 716-725].
Biomed Pharmacother. 2022 Jan;145:112510. doi: 10.1016/j.biopha.2021.112510. Epub 2021 Dec 9.
4
Retraction notice to "MiR-29b aggravates lipopolysaccharide-induced endothelial cells inflammatory damage by regulation of NF-κB and JNK signaling pathways" [Biomed. Pharmacother. 99 (2018) 451-461].对“MiR-29b通过调节NF-κB和JNK信号通路加重脂多糖诱导的内皮细胞炎症损伤”[《生物医学与药物治疗》99(2018)451-461]的撤稿通知
Biomed Pharmacother. 2022 Jul;151:112859. doi: 10.1016/j.biopha.2022.112859. Epub 2022 Mar 25.
5
Retraction notice to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282].
Biomed Pharmacother. 2024 Apr;173:116325. doi: 10.1016/j.biopha.2024.116325. Epub 2024 Mar 4.
6
Retraction notice to "Corrigendum to LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 133 (2020) 110893].
Biomed Pharmacother. 2024 Apr;173:116326. doi: 10.1016/j.biopha.2024.116326. Epub 2024 Mar 4.
7
Retraction notice to "Corrigendum to 'LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway'" [Biomed. Pharmacother. 111 (2019) 1508-1508].
Biomed Pharmacother. 2024 Apr;173:116327. doi: 10.1016/j.biopha.2024.116327. Epub 2024 Mar 5.
8
Retraction notice to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" Biomed. Pharmacother. 110(2019) 656-666.
Biomed Pharmacother. 2024 Aug;177:117098. doi: 10.1016/j.biopha.2024.117098. Epub 2024 Jul 5.
9
Retraction notice to "Knockdown of ANRIL aggravates HO-induced injury in PC-12 cells by targeting microRNA-125a" [Biomed. Pharmacother. 92 (2017) 952-961].
Biomed Pharmacother. 2022 Apr;148:112779. doi: 10.1016/j.biopha.2022.112779. Epub 2022 Mar 7.
10
Retraction notice to "Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis" [Biomed. Pharmacother. 124 (2020) 109858].撤回通知：“长链非编码RNA LINC00525通过靶向miR-338-3p/IRS2轴促进非小细胞肺癌进展”[《生物医学与药物治疗》124卷（2020年）109858]
Biomed Pharmacother. 2023 Apr;160:114278. doi: 10.1016/j.biopha.2023.114278. Epub 2023 Jan 31.
Zotero 插件